Paid Clinical Trials in Shirley, NY
As of August 2026, 25 paid clinical trials are recruiting in Shirley, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Shirley offers studies at sites including New York Cancer and Blood Specialists for conditions such as Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Shirley
Trials by drug in Shirley
Filter results
25 clinical trials
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Clinical Biospecimen Collection
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Top Research Study Locations in Shirley
Researchers run research studies in Shirley, NY at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| New York Cancer and Blood Specialists | Colorectal Neoplasms, Breast Neoplasms, CLL | 12 |
| North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists | Carcinoma, Non-Small Cell Lung, Colonic Diseases, Colorectal Neoplasms | 2 |
| NY Cancer and Blood Specialists | Chronic Primary Immune Thrombocytopenia (ITP), CRC (Colorectal Cancer) | 2 |
| Local Institution - 0079 | Carcinoma, Non-Small-Cell Lung | 1 |
| NYCBS | Cancer Risk | 1 |
| New York Cancer & Blood Specialists | Colorectal Cancer, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 1 |
| New York Cancer & Blood Specialists (NYCBS) | Metastatic Non-small Cell Lung Cancer | 1 |
| New York Cancer And Blood Specialists - Shirley | Non Small Cell Lung Carcinoma | 1 |
| New York Cancer and Blood Specialists One Oncology | Patients With Chemotherapy-Induced Thrombocytopenia | 1 |
| Suffolk Surgery Center | Lumbar Spinal Stenosis | 1 |
| Vitreoretinal Consultants | Geographic Atrophy, Macular Degeneration | 1 |
Active & Upcoming Studies in Shirley (2026)
Recruiting trials in Shirley grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (15 active studies)
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
Eye & vision (1 active study)
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy · Astellas Pharma Global Development, Inc.
Common conditions studied in Shirley
- Colorectal Neoplasms (3 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Esophageal Adenocarcinoma (2 active studies)
- Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Adenocarcinoma (1 active study)
- Breast Neoplasms (1 active study)
Leading research sponsors in Shirley
- Janssen Research & Development, LLC
- BeOne Medicines
- Bristol-Myers Squibb
- Eli Lilly and Company
- AVEO Pharmaceuticals, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Shirley?
There are approximately 25 recruiting clinical trials in Shirley, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Shirley pay participants?
Most recruiting trials in Shirley compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Shirley?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Shirley?
The most common conditions under active study in Shirley include Colorectal Neoplasms (3), Carcinoma, Non-Small-Cell Lung (2), Esophageal Adenocarcinoma (2), Gastroesophageal Junction Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Shirley?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shirley on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Shirley?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Shirley?
Recruiting research sites in Shirley include New York Cancer and Blood Specialists, North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, NY Cancer and Blood Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Shirley right now?
The largest active categories in Shirley are Cancer & tumors (15), Eye & vision (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.